IL17A and Alzheimer disease: Regarding immune mechanisms, complement components were identified as particular risk factors for AD by GWAS [52, 53], with clusterin modulating the complement system and various cytokines, including TNF-α [54], IL-2 [55], IL-17 [56], and membrane attack complex [57].